Sulima SO; Hofman IJ; De Keersmaecker K; Dinman JD
Cancer Discov 2017[Oct]; 7 (10): 1069-87 PMID28923911show ga
A wealth of novel findings, including congenital ribosomal mutations in ribosomopathies and somatic ribosomal mutations in various cancers, have significantly increased our understanding of the relevance of ribosomes in oncogenesis. Here we explore the growing list of mechanisms by which the ribosome is involved in carcinogenesis ? from the hijacking of ribosomes by oncogenic factors and dysregulated translational control, to the effects of mutations in ribosomal components on cellular metabolism. Of clinical importance, the recent success of RNA polymerase inhibitors highlights the dependence on ?onco-ribosomes? as an Achilles? heel of cancer cells and a promising target for further therapeutic intervention.